Literature DB >> 20175283

Comparison of 0.25% levobupivacaine and 0.25% bupivacaine for posterior approach interscalene brachial plexus block.

Semih Baskan1, Vildan Taspinar, Levent Ozdogan, Kemal Yetis Gulsoy, Gulcan Erk, Bayazit Dikmen, Nermin Gogus.   

Abstract

PURPOSE: This study compares the onset time and quality of posterior approach interscalene brachial plexus block produced by 0.25% levobupivacaine and 0.25% bupivacaine.
METHODS: Sixty adult patients undergoing open or closed shoulder surgery were enrolled in this double-blind, randomized study, and they were randomly allocated to receive 40 ml of 0.25% levobupivacaine (Group L, n = 30) or 0.25% bupivacaine (Group B, n = 30). The patients were assessed at 5 min intervals after local anesthetic injection in order to determine loss of shoulder abduction and loss of pinprick sensation in the C(5-6) dermatomes. The mean onset time of motor and sensory block and onset time of complete motor and sensory block were documented in both groups.
RESULTS: In both groups, mean onset time of sensory block was <5 min and mean onset time of complete sensory block was <25 min. The onset times for sensory block and complete sensory block were not statistically different between the groups (P > 0.05). In both groups, mean onset time of motor block was <10 min but the mean onset time of complete motor block was <30 min. The onset times of motor block and complete motor block were not statistically different among the groups (P > 0.05). After the injection of the local anesthetic, 27% of Group L and 87% of Group B had complete motor block. Four patients in Group L had no motor block.
CONCLUSION: We conclude that 0.25% levobupivacaine and 0.25% bupivacaine have similar motor and sensory block onset times and qualities when used in posterior approach interscalene brachial plexus block, and provide comfortable anesthesia and analgesia for shoulder surgery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20175283     DOI: 10.1007/s00540-009-0846-0

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  17 in total

Review 1.  Bupivacaine, levobupivacaine and ropivacaine: are they clinically different?

Authors:  Andrea Casati; Marta Putzu
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2005-06

2.  The deltoid sign.

Authors:  D N Wiener; K P Speer
Journal:  Anesth Analg       Date:  1994-07       Impact factor: 5.108

3.  A clinical comparison of ropivacaine 0.75%, ropivacaine 1% or bupivacaine 0.5% for interscalene brachial plexus anaesthesia.

Authors:  A Casati; G Fanelli; G Cappelleri; P Beccaria; L Magistris; B Borghi; G Torri
Journal:  Eur J Anaesthesiol       Date:  1999-11       Impact factor: 4.330

4.  Clinical efficacy of the brachial plexus block via the posterior approach.

Authors:  Ignace Sandefo; Gabriella Iohom; Alain Van Elstraete; Thierry Lebrun; Bruno Polin
Journal:  Reg Anesth Pain Med       Date:  2005 May-Jun       Impact factor: 6.288

5.  Onset time, quality of blockade, and duration of three-in-one blocks with levobupivacaine and bupivacaine.

Authors:  Bernhard Urbanek; Andreas Duma; Oliver Kimberger; Gudrun Huber; Peter Marhofer; Michael Zimpfer; Stephan Kapral
Journal:  Anesth Analg       Date:  2003-09       Impact factor: 5.108

6.  A comparison of 0.5% bupivacaine, 0.5% ropivacaine, and 0.75% ropivacaine for interscalene brachial plexus block.

Authors:  S M Klein; R A Greengrass; S M Steele; F J D'Ercole; K P Speer; D H Gleason; E R DeLong; D S Warner
Journal:  Anesth Analg       Date:  1998-12       Impact factor: 5.108

7.  Myocardial uptake of bupivacaine: II. Pharmacokinetics and pharmacodynamics of bupivacaine enantiomers in the isolated perfused rabbit heart.

Authors:  J X Mazoit; O Boïco; K Samii
Journal:  Anesth Analg       Date:  1993-09       Impact factor: 5.108

8.  Comparison of S(-)-bupivacaine with racemic (RS)-bupivacaine in supraclavicular brachial plexus block.

Authors:  C R Cox; M R Checketts; N Mackenzie; N B Scott; J Bannister
Journal:  Br J Anaesth       Date:  1998-05       Impact factor: 9.166

9.  Levobupivacaine for axillary brachial plexus block: a pharmacokinetic and clinical comparison in patients with normal renal function or renal disease.

Authors:  James C Crews; Robert S Weller; Jonathan Moss; Robert L James
Journal:  Anesth Analg       Date:  2002-07       Impact factor: 5.108

10.  The relative motor blocking potencies of epidural bupivacaine and ropivacaine in labor.

Authors:  Héctor J Lacassie; Malachy O Columb; Héctor P Lacassie; Rodrigo A Lantadilla
Journal:  Anesth Analg       Date:  2002-07       Impact factor: 5.108

View more
  8 in total

Review 1.  Levobupivacaine: a review of its use in regional anaesthesia and pain management.

Authors:  Mark Sanford; Gillian M Keating
Journal:  Drugs       Date:  2010-04-16       Impact factor: 9.546

2.  Nalbuphine as an adjuvant to 0.25% levobupivacaine in ultrasound-guided supraclavicular block provided prolonged sensory block and similar motor block durations (RCT).

Authors:  Bassant Mohamed Abdelhamid; Heba Omar
Journal:  J Anesth       Date:  2018-05-28       Impact factor: 2.078

3.  Bilateral superficial cervical plexus block combined with general anesthesia administered in thyroid operations.

Authors:  Ming-Lang Shih; Quan-Yang Duh; Chung-Bao Hsieh; Yao-Chi Liu; Chueng-He Lu; Chih-Shung Wong; Jyh-Cherng Yu; Chun-Chang Yeh
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

4.  Bispectral index-guided general anaesthesia in combination with interscalene block reduces desflurane consumption in arthroscopic shoulder surgery: a clinical comparison of bupivacaine versus levobupivacaine.

Authors:  Levent Ozturk; Elvin Kesimci; Tuna Albayrak; Orhan Kanbak
Journal:  BMC Anesthesiol       Date:  2015-07-21       Impact factor: 2.217

5.  The effect of intraarticular levobupivacaine and bupivacaine injection on the postoperative pain management in total knee artroplastic surgery.

Authors:  Nurcan Yavuz; Vildan Taspinar; Derya Karasu; Aysu Tezcan; Bayazit Dikmen; Nermin Gogus
Journal:  Pak J Med Sci       Date:  2014 Nov-Dec       Impact factor: 1.088

6.  Effect of Locally Administered Dexmedetomidine as Adjuvant to Levobupivacaine in Supraclavicular Brachial Plexus Block: Double-blind Controlled Study.

Authors:  Bikash Bisui; Swastika Samanta; Sumanta Ghoshmaulik; Amit Banerjee; Tirtha R Ghosh; Suman Sarkar
Journal:  Anesth Essays Res       Date:  2017 Oct-Dec

7.  Comparison of the onset time between 0.375% ropivacaine and 0.25% levobupivacaine for ultrasound-guided infraclavicular brachial plexus block: a randomized-controlled trial.

Authors:  Ha-Jung Kim; Sooho Lee; Ki Jinn Chin; Jin-Sun Kim; Hyungtae Kim; Young-Jin Ro; Won Uk Koh
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

8.  Effect of dexmedetomidine as an adjuvant to levobupivacaine in supraclavicular brachial plexus block: A randomized double-blind prospective study.

Authors:  Haramritpal Kaur; Gurpreet Singh; Sunita Rani; Kewal Krishan Gupta; Mukesh Kumar; Amanjot Singh Rajpal; Shobha Aggarwal
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2015 Jul-Sep
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.